Revathi Ananthakrishnan

41 papers receiving 4.0k citations

Revathi Ananthakrishnan's Hit Papers

Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer 2010 · 360 citations
3600+8+16Years since publication2505007501000

Peers

Revathi Ananthakrishnan
Comparison fields: 5 of 125
  • Cell Biology 1.6k
  • Biophysics 221
  • Biomedical Engineering 1.7k
  • Oncology 882
  • Atomic and Molecular Physics, and Optics 944
Replace Shiladitya Banerjee with:
Shiladitya Banerjee United Kingdom
Oliver Otto Germany
Steven S. Rosenfeld United States
Yingxiao Wang United States
Jeffrey R. Moore United States
Alexander R. Dunn United States
Matthew J. Paszek United States
Jacky G. Goetz France
Thomas P. Kole United States
Stephanie Alexander United States
Revathi Ananthakrishnan relative to Shiladitya Banerjee United Kingdom Shiladitya Banerjee's profile →
Citations per field
00.5×1.5×2.3×
Shiladitya Banerjee · 1×
Citations per year

Countries citing papers authored by Revathi Ananthakrishnan

Since Specialization
Citations

This map shows the geographic impact of Revathi Ananthakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Revathi Ananthakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Revathi Ananthakrishnan more than expected).

Fields of papers citing papers by Revathi Ananthakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Revathi Ananthakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Revathi Ananthakrishnan. The network helps show where Revathi Ananthakrishnan may publish in the future.

Co-authors

The 25 scholars most cited alongside Revathi Ananthakrishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Revathi Ananthakrishnan Line = papers co-authored together Revathi Ananthakrishnan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Optical Deformability as an Inherent Cell Marker for Testing Malignant Transformation and Metastatic Competence
Hit paper breakdown →
20051099
2
The Optical Stretcher: A Novel Laser Tool to Micromanipulate Cells
Hit paper breakdown →
2001721
3
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2010360
4 2007325
5 2000225
6 2005180
7 2013160
8 2011104
9 2017101
10 201297
11 201181
12 200676
13 200262
14 200548
15 201640
16 202240
17 201630
18 200726
19 201924
20 201322

About Revathi Ananthakrishnan

Revathi Ananthakrishnan is a scholar working on Oncology, Cell Biology, Statistics and Probability, Biomedical Engineering and Molecular Biology, having authored 44 papers that have together received 4.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Cellular Mechanics and Interactions (8 papers), Statistical Methods in Clinical Trials (8 papers), Biosimilars and Bioanalytical Methods (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), 3D Printing in Biomedical Research (5 papers), Microfluidic and Bio-sensing Technologies (4 papers) and Computational Drug Discovery Methods (4 papers). The work is most often cited by research in Cell Biology (1.6k citations), Biophysics (221 citations), Biomedical Engineering (1.7k citations), Oncology (882 citations) and Atomic and Molecular Physics, and Optics (944 citations). Revathi Ananthakrishnan has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Josef A. Käs, Jochen Guck, C. Casey Cunningham, Allen J. Ehrlicher, Tess J. Moon, Stefan Schinkinger, Bryan Lincoln, Falk Wottawah, Curt Bilby and Dominik Lenz. Their work appears in journals such as Blood, Journal of Clinical Oncology, Critical Reviews in Oncology/Hematology, Biophysical Journal and Therapeutic Innovation & Regulatory Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact